Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRotork Regulatory News (ROR)

Share Price Information for Rotork (ROR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 328.80
Bid: 331.20
Ask: 331.60
Change: -0.60 (-0.18%)
Spread: 0.40 (0.121%)
Open: 327.20
High: 332.00
Low: 327.20
Prev. Close: 329.40
ROR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading update

25 Nov 2020 07:00

RNS Number : 3913G
Rotork PLC
25 November 2020
 

25 November 2020

Rotork Plc

Trading update

Improved resilience demonstrated and guidance reinstated

Rotork plc ("Rotork"), the global flow control and instrumentation group, today issues the following trading update covering the four months to 1 November 2020.

Trading update

Order intake in the third quarter showed sequential improvement, whilst remaining lower year-on-year on an OCC1 basis, with the decline slightly less than the 15.6% experienced in the first half. The majority of Rotork's activity is driven by customers' operational rather than capital expenditure and they continue to spend on automation and environmental projects as well as maintenance and refurbishment. Large project activity has remained subdued.

During the third quarter Group revenues were at 97% of the 2019 level on an OCC basis, an improvement on the first-half's 9.6% year-on-year decline. The third quarter performance largely reflected reduced activity at Rotork Site Services.

Oil & Gas sales declined more than the Group, with revenue higher year-on-year in the quarter in EMEA and Asia Pacific, but lower in the Americas. Water & Power sales grew, continuing the encouraging performance seen earlier in the year. Trading conditions remained mixed at CPI, however the Asia Pacific region returned to year-on-year growth. Overall, CPI revenue was down less than in the first half (when CPI sales were 16.8% lower).

Third quarter adjusted operating profit margins benefited from continued execution of the Growth Acceleration Programme and other management actions and we now anticipate full-year margin progress year-on-year, absent any further Covid-19 related disruption to operations.

Our Growth Acceleration Programme is on track. Our innovation and new product development initiatives are progressing well and the second half features several important launches. Our factory footprint optimisation work continues, and we recently formally opened our expanded Rochester, New York, facility. The regional back office simplification initiative is well under way.

Rotork remains highly cash generative with a strong balance sheet. Net cash at 1 November 2020 was £146.8m (£106.1m at 31 December 2019 including £10.7m of lease liabilities) after paying an interim dividend on 25 September 2020 of £34.0m in lieu of the deferred 2019 final dividend.

Covid-19 update

Our priority is the health and safety of our colleagues and their families, our customers, and suppliers. We continue to take decisive actions to manage the Covid-19 situation.

All our production facilities are currently open, albeit in a small number of cases operating at below normal output levels. Whilst every effort is being made to keep our facilities open, we will not hesitate to close them if required or if we believe there is any risk to our colleagues or their families.

Outlook

The Group's performance in the first ten months has demonstrated the improved resilience of the business. Although there remains uncertainty on the continuing impact of the Covid-19 pandemic, and risks of temporary factory closures and logistics issues, we expect 2020 adjusted operating profit to be at, or slightly above, the top end of the range of current market expectations2.

Rotork will publish 2020 full-year results on Tuesday 2 March 2021.

¹ OCC is organic constant currency results excluding discontinued businesses and restated at 2019 exchange rates

2 The current range of market expectations (company compiled) for 2020 adjusted operating profit is £124m-136m

 

Enquiries:

Rotork plc Tel: +44 (0)1225 733 200

Kevin Hostetler, Chief Executive

Jonathan Davis, Finance Director

Andrew Carter, Investor Relations Director

 

FTI Consulting Tel: + 44 (0)20 3727 1340

Nick Hasell / Susanne Yule

 

About Rotork

Rotork is a market-leading global provider of mission-critical flow control and instrumentation solutions for oil & gas, water and wastewater, power, chemical process and industrial applications. We help customers around the world to improve efficiency, reduce emissions, minimise their environmental impact and assure safety. Rotork employs about 3,500 people, has manufacturing facilities in more than 20 locations and serves 173 countries through a global service network. Its shares have a premium listing on the London Stock Exchange (symbol: ROR) and are a constituent of the FTSE 250 index. For more information please visit www.rotork.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFETLALSFII
Date   Source Headline
29th Sep 20164:29 pmRNSHolding(s) in Company
5th Sep 20162:19 pmRNSHolding(s) in Company
2nd Aug 20167:00 amRNSHalf-year Report
4th Jul 201610:13 amRNSTotal Voting Rights
4th Jul 201610:11 amRNSBlock listing Interim Review
4th Jul 201610:11 amRNSHolding(s) in Company
24th Jun 20165:03 pmRNSHolding(s) in Company
1st Jun 201610:54 amRNSTotal Voting Rights
26th May 20162:54 pmRNSDirector Declaration
3rd May 201610:16 amRNSTotal Voting Rights
29th Apr 20164:06 pmRNSResult of AGM
29th Apr 20167:00 amRNSAcquisition of Mastergear
29th Apr 20167:00 amRNSTrading Update
27th Apr 20169:20 amRNSHolding(s) in Company
1st Apr 201610:06 amRNSTotal Voting Rights
29th Mar 20169:45 amRNSDoc re. AGM Documents
1st Mar 20169:07 amRNSTotal Voting Rights
1st Mar 20167:00 amRNSFinal Results
18th Feb 20161:47 pmRNSHolding(s) in Company
4th Jan 201610:04 amRNSBlocklisting Interim Review
4th Jan 201610:02 amRNSTotal Voting Rights
18th Nov 20157:00 amRNSCapital Markets Day
13th Nov 20157:00 amRNSTrading Update
22nd Oct 201510:22 amRNSHolding(s) in Company
29th Sep 20157:00 amRNSAcquisitions
24th Sep 201510:38 amRNSDirector/PDMR Shareholding
21st Sep 20151:08 pmRNSDirector/PDMR Shareholding
21st Sep 20151:07 pmRNSDirector/PDMR Shareholding
18th Sep 201512:41 pmRNSDirector/PDMR Shareholding
17th Sep 20157:00 amRNSTrading Update
16th Sep 20159:54 amRNSDirector/PDMR Shareholding
28th Aug 20157:00 amRNSAcquisition of Bifold Group
12th Aug 20153:57 pmRNSHolding(s) in Company
4th Aug 20157:01 amRNSAcquisition
4th Aug 20157:00 amRNS2015 Half Year Results
3rd Aug 20158:37 amRNSTotal Voting Rights
1st Jul 20159:00 amRNSBlocklisting Interim Review
1st Jul 20159:00 amRNSTotal Voting Rights
2nd Jun 201511:41 amRNSTotal Voting Rights
20th May 20159:19 amRNSBlock Listing Application
18th May 20151:03 pmRNSSHARE SUBDIVISION
15th May 201512:08 pmRNSSHARE SUBDIVISION
8th May 201512:38 pmRNSBlocklisting Interim Review
1st May 20159:38 amRNSTotal Voting Rights
28th Apr 20154:19 pmRNSHolding(s) in Company
24th Apr 20154:06 pmRNSResult of AGM
24th Apr 20157:00 amRNSTrading Update
14th Apr 20155:01 pmRNSDoc re. AGM Documents
1st Apr 201512:43 pmRNSTotal Voting Rights
24th Mar 201512:43 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.